Rejects Shareholder’s Appeal that Company Now Work for Free-Market, Constitutional Health Care Reforms Indianapolis, IN / Washington, D.C. – Today, at Eli Lilly’s annual shareholder meeting in Indianapolis, Indiana, the National Center for Public Policy Research questioned CEO Dr. John Lechleiter over his company’s financial … Continue reading Eli Lilly CEO Firmly Stands By Company’s Pro-ObamaCare Lobbying at Shareholder Meeting